Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Congratulations to all the winners of Cancer Research Horizons’ second Innovation & Entrepreneurship Awards:
Ishani Malhotra won Woman Entrepreneur of the Year, Matt de Vries won Early-career Entrepreneur of the Year and Maike de la Roche Entrepreneurial Group Leader of the Year. Dotplot were awarded New Start-up of the Year and University of Dundee, Boehringer Ingelheim, University of Edinburgh and Nuvectis won Further, Faster, Together (Industry-Academia Collaboration).
Nitzan Rosenfeld won the Entrepreneurship Recognition Award and Bart Vanhaesebroeck the Horizons Explorer Recognition Award. Artios Pharma were given the Start-up Achievement Recognition Award.
Alessia Errico, Associate Director of Search & Evaluation and Entrepreneurial Programme Lead at Cancer Research Horizons, praised the winners and participants for their pivotal role in translating breakthroughs into positive outcomes. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
| | Getting a deeper understanding of immunology for early cancer detection |
| | The emergence of liquid biopsies is a step forward for the future of cancer early detection, but what biomarkers should we be looking for?
Evie Fitzsimons, a PhD student at the UCL Cancer Institute, says that part of the answer to this huge question could be in our immune system.
Writing in Cancer News, Evie explains the potential of a multi-parametric immunopredictor of early-stage cancer focusing on cytokines, antibodies and T-cell receptors. |
| | |
|
|
|---|
|
|
|
|
|
| | | | Are you interested in mechanistic insights to inform prevention strategies?
Hear from Frances Balkwill (Queen Mary University London) and Catriona Jamieson (University of California San Diego), who will co-chair a session showcasing examples from discovery research highlighting the underlying mechanistic understanding to shed light on cancer and pre-cancer genesis at the prevention conference in Boston.
They will be joined by Ahmed Ahmed (Oxford University), Wendy Garrett (Harvard University), and Thea Tlsty (University of California San Francisco) who will address the future precision prevention interventions through mechanistic understanding followed by a thought-provoking discussion.
Follow #PrevConf24 on our socials for more agenda updates. | | |
| | | | | | We’re partnering with the Norwegian Cancer Society to share expertise and funding to ensure more of the most promising drug candidates progress swiftly to the clinic.
Lars Erwig, Director of our Centre for Drug Development (CDD), said the partnership will be vital in helping to identify and advance encouraging projects which the CDD will lead through early phase trials. | | |
|
|---|
|
|
|
|
Session chairs announced for our brain tumour conference |
| Join us for our flagship Brain Tumour Conference, taking place in London, on 24-26 September, for three days of thought-provoking scientific conversation and networking with peers and experts from all over the world.
Recently confirmed session chairs include Claudia Kleinman (McGill University), Omer Bayraktar (Wellcome Sanger Institute), Bissan Al-Lazikani (MD Anderson Cancer Center), Simona Parrinello (University College London), Craig Thompson (Memorial Sloan Kettering Cancer Center), Erica Sloan (Monash University) and Darren Hargrave (University College London/Great Ormond Street Hospital).
There’s still time to submit an abstract and join the conference programme, either giving a short talk or presenting a poster.
Submission deadline is 24 May.
|
| | |
|
|
|
| | | | Join this lunchtime webinar hosted by the Cancer Research UK City of London Centre which will explore ways to evaluate and think objectively when faced with negative experiments, publications and grant application outcomes which are inevitable for every researcher.
It will kick off with presentations from Kairbaan Hodivala-Dilke from Barts Cancer Institute and Charles Swanton, Francis Crick Institute and City of London Centre. This will be followed by a panel Q&A with colleagues based across the network of our Centres including Nicki Flaum, Cancer Research UK Manchester Centre and Claire King, Cancer Research UK Cambridge Centre. This free webinar is open to all researchers, you do not need to be based at one of our Centres. | | |
| | | | | | Have you published a paper in the last three years that has or could have major impacts on the replacement, reduction or refinement of the use of animals in research? Apply for the annual international NC3Rs prize and gain recognition for your original work with demonstrable 3Rs impacts.
The award consists of a £28k prize grant and a £2k personal award.
Papers which are not awarded the NC3Rs prize could still secure a £4k prize grant and a £1k personal award if they are highly commended by the judging panel.
The deadline to apply is 1 May 2024.
| | |
|
|---|
|
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | You are playing a crucial role in helping us beat cancer sooner, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
